Suggested objective performance goals and clinical trial design for evaluating catheter-based treatment of critical limb ischemia
Top Cited Papers
Open Access
- 9 November 2009
- journal article
- editorial
- Published by Elsevier
- Vol. 50 (6) , 1462-1473.e3
- https://doi.org/10.1016/j.jvs.2009.09.044
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Premarket assessment of devices for treatment of critical limb ischemia: The role of Objective Performance Criteria and GoalsJournal of Vascular Surgery, 2009
- Adjunctive parenteral therapy with lipo-ecraprost, a prostaglandin E1 analog, in patients with critical limb ischemia undergoing distal revascularization does not improve 6-month outcomesJournal of Vascular Surgery, 2007
- FDA perspective on clinical trial design for femoropopliteal stent correction of peripheral vascular insufficiency cardiovascular devicesCatheterization and Cardiovascular Interventions, 2007
- Performance goals and endpoint assessments for clinical trials of femoropopliteal bare nitinol stents in patients with symptomatic peripheral arterial diseaseCatheterization and Cardiovascular Interventions, 2007
- Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)Journal of Vascular Surgery, 2007
- Prosthetic Heart Valves: Objective Performance Criteria Versus Randomized Clinical TrialThe Annals of Thoracic Surgery, 2006
- FDA Perspective on Clinical Trial Design for Cardiovascular DevicesThe Annals of Thoracic Surgery, 2006
- Parenteral therapy with lipo-ecraprost, a lipid-based formulation of a PGE1 analog, does not alter six-month outcomes in patients with critical leg ischemiaJournal of Vascular Surgery, 2006
- Results of PREVENT III: A multicenter, randomized trial of edifoligide for the prevention of vein graft failure in lower extremity bypass surgeryJournal of Vascular Surgery, 2006
- Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trialThe Lancet, 2005